164
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

An Economic Synthesis of New Thiazole Derivative as a Potent Anticancer, Anti-Antibiotic Resistant Bacteria, and Larvicidal Agent

ORCID Icon, , , , , , , , & show all
Pages 6537-6545 | Received 26 Jul 2021, Accepted 17 Sep 2021, Published online: 29 Sep 2021

References

  • A. Satoh, Y. Nagatomi, Y. Hirata, S. Ito, G. Suzuki, T. Kimura, S. Maehara, H. Hikichi, A. Satow, M. Hata, et al. “Discovery and In Vitro and In Vivo Profiles of 4-Fluoro-N-[4-[6-(Isopropylamino)Pyrimidin-4-yl]-1,3-Thiazol-2-yl]-N-Methylbenzamide as Novel Class of an Orally Active Metabotropic Glutamate Receptor 1 (mGluR1) Antagonist,” Bioorganic & Medicinal Chemistry Letters 19, no. 18 (2009): 5464–8.
  • N. Siddiqui and W. Ahsan, “Synthesis, Anticonvulsant and Toxicity Screening of Thiazolyl–Thiadiazole Derivatives,” Medicinal Chemistry Research 20, no. 2 (2011): 261–8.
  • B. S. Dawane, S. G. Konda, G. G. Mandawad, and B. M. Shaikh, “ Poly(Ethylene Glycol) (PEG-400) as an Alternative Reaction Solvent for the Synthesis of Some New 1-(4-(4′-Chlorophenyl)-2-Thiazolyl)-3-Aryl-5-(2-Butyl-4-Chloro-1H-Imidazol-5yl)-2-Pyrazolines and Their In Vitro Antimicrobial Evaluation ,” European Journal of Medicinal Chemistry 45, no. 1 (2010): 387–92.
  • N. Adibpour, A. Khalaj, and S. Rajabalian, “Synthesis and Antibacterial Activity of Isothiazolyl Oxazolidinones and Analogous 3(2H)-Isothiazolones,” European Journal of Medicinal Chemistry 45, no. 1 (2010): 19–24.
  • S. M. Sondhi, N. Singh, A. M. Lahoti, K. Bajaj, A. Kumar, O. Lozach, and L. Meijer, “Synthesis of Acridinyl-Thiazolino Derivatives and Their Evaluation for Anti-Inflammatory, Analgesic and Kinase Inhibition Activities,” Bioorganic & Medicinal Chemistry 13, no. 13 (2005): 4291–9.
  • N. Singh, S. K. Bhati, and A. Kumar, “Thiazolyl/Oxazolyl Formazanyl Indoles as Potent Anti-Inflammatory Agents ,” European Journal of Medicinal Chemistry 43, no. 11 (2008): 2597–609.
  • E. L. Luzina and A. V. Popov, “Synthesis and Anticancer Activity of N-Bis(Trifluoromethyl)Alkyl-N'-Thiazolyl and N-Bis(Trifluoromethyl)Alkyl-N'-Benzothiazolyl Ureas ,” European Journal of Medicinal Chemistry 44, no. 12 (2009): 4944–53.
  • Tomoharu Iino, Noriaki Hashimoto, Kaori Sasaki, Sumika Ohyama, Riki Yoshimoto, Hideka Hosaka, Takuro Hasegawa, Masato Chiba, Yasufumi Nagata, Jun-ichi Eiki, et al. “Structure–Activity Relationships of 3,5-Disubstituted Benzamides as Glucokinase Activators With Potent In Vivo Efficacy ,” Bioorganic & Medicinal Chemistry 17, no. 11 (2009): 3800–9.
  • R. K. Rawal, R. Tripathi, S. B. Katti, C. Pannecouque, and E. D. Clercq, “Design and Synthesis of 2-(2,6-Dibromophenyl)-3-Heteroaryl-1,3-Thiazolidin-4-Ones as Anti-HIV Agents,” European Journal of Medicinal Chemistry 43, no. 12 (2008): 2800–6.
  • M. R. Shiradkar, K. C. Akula, V. Dasari, V. Baru, B. Chiningiri, S. Gandhi, and R. Kaur, “Clubbed Thiazoles by MAOS: A Novel Approach to Cyclin-Dependent Kinase 5/p25 Inhibitors as a Potential Treatment for Alzheimer's Disease ,” Bioorganic & Medicinal Chemistry 15, no. 7 (2007): 2601–10.
  • G. Turan-Zitouni, P. Chevallet, F. S. Kiliç, and K. Erol, “Synthesis of Some Thiazolyl-Pyrazoline Derivatives and Preliminary Investigation of Their Hypotensive Activity,” European Journal of Medicinal Chemistry 35, no. 6 (2000): 635–41.
  • M. H. Shih and F. Y. Ke, “Syntheses and Evaluation of Antioxidant Activity of Sydnonyl Substituted Thiazolidinone and Thiazoline Derivatives,” Bioorganic & Medicinal Chemistry 12, no. 17 (2004): 4633–43.
  • M. Britschgi, S. Greyerz, C. Burkhart, and W. J. Pichler, “Molecular Aspects of Drug Recognition by Specific T Cells,” Current Drug Targets 4, no. 1 (2003): 1–11.
  • M. P. Knadler, R. F. Bergstrom, J. T. Allaghan, and A. L. A. N. Rubin, “Nizatidine, an H2-Blocker. Its Metabolism and Disposition in Man,” Drug Metabolism and Disposition: The Biological Fate of Chemicals 14, no. 2 (1986): 175–82.
  • D. Lednicer, and L. A. Mitscher, Organic Chemistry of Drug Synthesis, Vol. 4 (New York: Wiley, 1990), 95.
  • J. S. Carter, S. Kramer, J. J. Talley, T. Penning, P. Collins, M. J. Graneto, K. Seibert, C. Koboldt, J. Masferrer, and B. Zweifel, “Synthesis and Activity of Sulfonamide-Substituted 4,5-Diaryl Thiazoles as Selective Cyclooxygenase-2 Inhibitors,” Bioorganic & Medicinal Chemistry Letters 9, no. 8 (1999): 1171–4.
  • K. D. Hargrave, F. K. Hess, and J. T. Oliver, “N-(4-Substituted-Thiazolyl)Oxamic Acid Derivatives, A New Series of Potent, Orally Active Antiallergy Agents,” Journal of Medicinal Chemistry 26, no. 8 (1983): 1158–63.
  • S. Bondock, W. Khalifa, and A. A. Fadda, “Synthesis and Antimicrobial Evaluation of Some New Thiazole, Thiazolidinone and Thiazoline Derivatives Starting from 1-Chloro-3,4-Dihydronaphthalene-2-Carboxaldehyde,” European Journal of Medicinal Chemistry 42, no. 7 (2007): 948–54.
  • W. C. Patt, H. W. Hamilton, M. D. Taylor, M. J. Ryan, D. G. Taylor, Jr., C. J. C. Connolly, A. M. Doherty, S. R. Klutchko, I. Sircar, B. A. Steinbaugh, et al. “ Structure–Activity Relationships of a Series of 2-Amino-4-Thiazole-Containing Renin Inhibitors ,” Journal of Medicinal Chemistry 35, no. 14 (1992): 2562–72.
  • P. K. Sharma, S. N. Sawhney, A. Gupta, G. B. Singh, and S. Bani, “Synthesis and Antiinflammatory Activity of Some 3-(2-Thiazolyl)-1,2-Benzisothiazoles,” Indian Journal of Chemistry 37B (1998): 376–81.
  • N. Ergenc, G. Capan, N. S. Gunay, S. ¨Ozkirimli, M. Gungor, S. ¨Ozbey, and E. Kendi, “Synthesis and Hypnotic Activity of New 4-Thiazolidinone and 2-Thioxo-4,5-Imidazolidinedione Derivatives,”Archiv der Pharmazie 332, no. 10 (1999): 343–7.
  • F. W. Bell, A. S. Cantrell, M. Hogberg, S. R. Jaskunas, N. G. Johansson, C. L. Jordon, M. D. Kinnick, P. Lind, J. M. Morin, Jr, R. Noreen, et al. “Phenethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure–Activity Relationship Studies of PETT Analogs,” Journal of Medicinal Chemistry 38, no. 25 (1995): 4929–36.
  • C. L. Ventola, “The Antibiotic Resistance Crisis: Part 1: Causes and Threats,” Pharmacology & Therapeutics 40 (2015): 277–83.
  • H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–49.
  • (a) Y. N. M. Gabr, J. M. A. Khaled, M. A. S. Sultan, S. S. Al-Showiman, N. S. H. A. Alharbi, H. A. Ghabbour, (US Patent No. 9,988,348, Washington, DC: U.S. Patent and Trademark Office, 2018); (b) Y. M. Mabkhot, J. M. Khaled, M. A. Sultan, N. S. Alharbi, S. S. Al-Showiman, H. A. Ghabbour, A. Alsayari, A. B. Muhsinah, and H. Algarni, “The novel economical synthesis and antimicrobial activity of a trithiocarbonate derivative,” Bioorganic Chemistry 91 (2019): 103157.
  • (a) Y. N. Mabkhot, J. M. A. Khaled, M. A. Sultan, F. A. N. Mohammed, N. S. H. A. Alharbi, S. S. Al-Showiman, H. A. Ghabbour, (US Patent No. 10,071,960. Washington, DC: U.S. Patent and Trademark Office, 2020). (b) Y. N. Mabkhot, J. M. A. Khaled, M. A. S. Sultan, N. S. H. A. Alharbi, H. A. Ghabbour, F. A. Nasr, A. Alsayari, A. B. Muhsinah, H. Algarni, and Y. I. Asiri, “Synthesis and Biological Screening of a Novel Enaminone-Grafted Trithiocarbonate: A Potential Anticancer and Antimicrobial Agent,” Medicinal Chemistry Research 29, no. 6 (2020): 954 − 61.
  • Y. N. Mabkhot, J. M. A. Khaled, N. S. H. A. Alharbi, F. A. N. Mohammed, F. A. Almekhlafi, N. M. Abutaha, S. S. Al-Showiman, (US Patent No. 10,501,426, Washington, DC: U.S. Patent and Trademark Office, 2019).
  • M. Soleiman-Beigi and Z. Taherinia, “An Efficient One-​Pot Approach to the Synthesis of Symmetric Trithiocarbonates from Carbon Disulfide and Alkyl Halides Using Imidazole,” Journal of Sulfur Chemistry 35, no. 5 (2014): 470–6.
  • G. M. Sheldrick, SHELXTL-PC (Version 5.1) (Madison, WI, USA: Siemens Analytical Instruments Inc., 1997).
  • G. M. Sheldrick, “A Short History of SHELX,” Acta Crystallographica. Section A, Foundations of Crystallography 64, no. Pt 1 (2008): 112–22.
  • H. H. Lara, N. V. Ayala-Núnez, L. D. C. I. Turrent, and C. R. Padilla, “Bactericidal Effect of Silver Nanoparticles against Multidrug-Resistant Bacteria,” World Journal of Microbiology and Biotechnology 26, no. 4 (2010): 615–21.
  • A. M. Ahmed, P. Taylor, R. Maingon, and H. Hurd, “The Effect of Plasmodium yoelii nigeriensis on the Reproductive Fitness of Anopheles gambiae,” Invertebrate Reproduction & Development 36, no. 1–3 (1999): 217–22.
  • F. A. Al-Mekhlafi, “Larvicidal, Ovicidal Activities and Histopathological Alterations Induced by Carum copticum (Apiaceae) Extract Against Culex pipiens (Diptera: Culicidae)),” Saudi Journal of Biological Sciences 25, no. 1 (2018): 52–6.
  • G. Capozzi, G. Modena, “Ch. 17,” in The Chemistry of the Thiol Group, Part 2, edited by S. Patai (London: John & Sons, 1974), 801, and references cited therein.
  • Y. N. Mabkhot, A. Alsayari, A. Bin Muhsinah, H. Algarni, S. M. Soliman, N. A. Kheder, H. A. Ghabbour, Y. I. Asiri, M. H. Mahnash, S. Tasqeeruddin, et al. “Synthesis, X-Ray Structural Analysis and Computational Studies of a Novel Bis (2-Thienyl) Disulfide Derivative,” Polycyclic Aromatic Compounds (2020): 1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.